Research LettersAssociation of mannose-binding-lectin deficiency with severe atherosclerosis
References (5)
- et al.
Chronic infections and coronary heart disease: is there a link?
Lancet
(1997) Mannose-binding lectin: the pluripotent molecule of the innate immune system
Immunol Today
(1996)
There are more references available in the full text version of this article.
Cited by (146)
The multifaceted impact of complement on atherosclerosis
2022, AtherosclerosisFicolin-2 serum levels predict the occurrence of acute coronary syndrome in patients with severe carotid artery stenosis
2021, Pharmacological ResearchCitation Excerpt :Mannose-binding lectin (MBL) was the first discovered and thus more widely studied initiator of the LP. A few studies reported MBL involvement in atherosclerosis supporting either an anti-atherogenic [38–42] or a pro-atherogenic [43–45] role, possibly depending on disease process and specific clinical setting [43,46]. In the present work we observed negligible correlations of MBL serum levels with circulating, hematologic and intraplaque components.
Plasma levels of mannose-binding lectin and future risk of venous thromboembolism
2019, Journal of Thrombosis and HaemostasisEfferocytosis and Atherosclerosis: Regulation of Phagocyte Function by MicroRNAs
2019, Trends in Endocrinology and Metabolism
Copyright © 1998 Elsevier Ltd. All rights reserved.